Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

New Contracts and Products Help Emergent BioSolutions Inc Get It Done

TheMotleyFool

0 0

New Contracts and Products Help Emergent BioSolutions Inc Get It Done

Emergent BioSolutions (NYSE: EBS) continues toward its goal of having $1 billion in revenue in 2020 with a solid third-quarter performance that exceeded its own guidance of revenue in the range of $115 million to $130 million.

Metric

Q3 2017

Source: Fool.com